AZT new appointments

  • Dec 23, 2019 AEDT
  • Team Kalkine

Azure Health Technology Limited (ASX: AZT) has announced that Mr Lou Panaccio has been appointed to the board as an independent non-executive Chairman and Dr Glenn Tong has been appointed to the board as a non-executive director.

These appointments are part of the process towards the acquisition of Invictus Biopharma Ltd. Once the acquisition of Invictus is complete, it is proposed that Dr Tong will be appointed as the Chief Executive Officer and Managing Director of the Company

Mr Panaccio possesses more than 30 years’ executive leadership experience in healthcare services and life sciences and Dr Tong has over 20 years of executive management and Board experience in rapid growth biotech companies.


All pictures are copyright to their respective owner(s) does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK